Kolbinger, Fiona R. http://orcid.org/0000-0003-2265-4809
Veldhuizen, Gregory P.
Zhu, Jiefu
Truhn, Daniel http://orcid.org/0000-0002-9605-0728
Kather, Jakob Nikolas http://orcid.org/0000-0002-3730-5348
Article History
Received: 18 August 2023
Accepted: 27 March 2024
First Online: 11 April 2024
Competing interests
: D.T. holds shares in StratifAI GmbH and has received honoraria for lectures from Bayer. J.N.K. declares consulting services for Owkin, France, DoMore Diagnostics, Norway, Panakeia, UK, Scailyte, Switzerland, Cancilico, Germany, Mindpeak, Germany, MultiplexDx, Slovakia, and Histofy, UK; furthermore, he holds shares in StratifAI GmbH, Germany, has received a research grant by GSK, and has received honoraria by AstraZeneca, Bayer, Eisai, Janssen, MSD, BMS, Roche, Pfizer and Fresenius. All other authors declare no conflicts of interest.